Fate Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. HOOD
9. DFTX
10. IBM

Go back to Fate Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.15 +0.06 (2.87%)
Previous Close $2.09    52 Week High $4.76 
Open $2.07    52 Week Low $1.46 
Day High $2.23    P/E N/A 
Day Low $2.01    EPS $-1.91 
Volume 5,698,136